 The study in the labeled and real conditions of prescription of Actonel will investigate the satisfaction of patients with its new formulation: 35 mg Once A Week. The study will also measure response rates in CTX the C-telopeptide of type I collagen at baseline and after 12 weeks of treatment with risedronate 35 mg Once A Week. 